Use of Tocilizumab Drug Levels to Optimize Treatment in RA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Use of Tocilizumab Drug Levels to Optimize Treatment in RA — Stella

Home/Rheumatoid Arthritis/

View on ClinicalTrials.gov

Recruiting

Back to Rheumatoid Arthritis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Netherlands

Reade Rheumatology Research Institute, Amsterdam

Key details

Phase

Post-approval study

Sponsor

Reade Rheumatology Research Institute

Collaborators

ZonMw: The Netherlands Organisation for Health Research and Development

Enrollment target

~98 participants

Started

March 2020

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.